CN Stock MarketDetailed Quotes

603233 DaShenLin Pharmaceutical Group

Watchlist
  • 12.97
  • -0.28-2.11%
Market Closed Sep 10 15:00 CST
14.77BMarket Cap16.29P/E (TTM)

DaShenLin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Chinese and western proprietary medicine9.96B74.63%
Non-drug1.56B11.72%
中参药材1.52B11.35%
Other business307.1M2.30%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Retail sales11.06B82.91%
加盟及分销1.97B14.79%
Other business307.1M2.30%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
South China8.6B64.48%
东北、华北、西南及西北地区2.23B16.68%
Central China1.2B8.98%
East China region1.01B7.56%
Other business307.1M2.30%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg